Venrock
Palo Alto, CA · Invests in US · Website
Check size
🔒 $•• – $••Thesis
Backs bold founders in technology and healthcare building companies that will define the future of their industries. Two practice areas: Enterprise/AI (AI infrastructure, frontier systems, cybersecurity, defense, fintech, developer tools) and Healthcare/Life Sciences (digital health, therapeutics, genomics, health system modernization). Deep partnership model, long-term patient capital approach across market cycles since 1969.
Likely not a fit for
No consumer social, gaming, or single-product hardware plays without platform ambitions
How they invest
- Lead or follow
- Usually leads
- Typical decision
- ~1 month
- Warm intro
- Preferred
- Involvement
- Takes a board seat
- Fund status
- Actively deploying
- Assets under mgmt
- $3B
- Decision process
- Partnership vote
Partners & team
11 contacts on file
e•••@ve•••.com
Sign up free to unlock contact →b•••@ve•••.com
Sign up free to unlock contact →t•••@ve•••.com
Sign up free to unlock contact →LinkedIn profile
Sign up free to unlock contact →Portfolio
Alto Neuroscience is a company focused on precision psychiatry and developing personalized psychiatric treatments, leveraging the biology of individuals' brains to create effective medicines.
Tubulis generates uniquely matched antibody-drug conjugates with superior biophysical properties that have demonstrated durable on-tumor delivery and long-lasting anti-tumor activity in preclinical models.
Euclid Power provides renewable energy project development solutions, empowering teams to deliver projects with speed, precision, and ease. They offer a full suite of services across the renewable energy project lifecycle, including development, investment, and construction.
Zero Networks is dedicated to simplifying microsegmentation for security professionals by combining microsegmentation, identity-based access control, and advanced ZTNA into one unified platform, empowering organizations to achieve true Zero Trust architecture.
X4 is delivering progress for patients by developing and commercializing innovative therapies for those with rare diseases of the immune system and significant unmet needs. Leveraging our expertise in CXCR4 and immune system biology, we have successfully developed mavorixafor, which has received U.S. approval as XOLREMDI® (mavorixafor) capsules in its first indication.
Stride provides a complete suite of portable benefits for independent workers, including health insurance, dental, vision, and life plans, along with tools for tax preparation and savings.
Salsify provides a Product Experience Management (PXM) platform that helps brands and retailers manage product content and optimize the digital shelf.
Biohaven Pharmaceuticals is a biopharmaceutical company focused on developing treatments for neurological and oncology diseases, known for its migraine treatments including Nurtec ODT and Zavzpret.
Astronomer provides a fully-managed data operations platform powered by Apache Airflow, enabling organizations to streamline their data workflows and enhance data observability.
Recent activity
- Mar 2026
Korro Bio
Private Placement · Lead
- Feb 2026
GenLogs
Series B · Co-Lead
- Feb 2026
Angitia
Series D · Participated
- Sep 2025
Maze Therapeutics
Late Stage · Participated
- Jun 2025
Zero Networks
Series C · Participated
- May 2025
Astronomer
Series D · Participated
Venrock in the news
InvestmentNews
Altruist investor "always thought an IPO would be possible"
6 days ago
FinTech Futures
Wealthtech Arca exits stealth with $64m
2 months ago
WSJ
Exclusive | Startup Arca Raises Fresh $48.5 Million to Disrupt the Wealth Advisory Business
2 months ago
STAT
A biotech VC on what Eli Lilly saw in a struggling cancer startup for $3.2B
4 months ago
Crunchbase News
Lilly Acquiring Kelonia In Largest Funded Biotech Startup Purchase In Years
4 months ago
InvestmentNews
Finny closes $17M Series A to help RIAs fight organic growth squeeze
8 months ago
Fortune
AI doctors will be good at science but bad at business, and big talk with little action means even higher drugs prices: 10 healthcare predictions for 2026 from top investors
9 months ago
The Aerospace Corporation
Ray Rothrock
10 months ago
Business Wire
Euclid raises $20M Series A led by Venrock to accelerate renewable energy projects with its AI-driven platform and services
Sep 2025
Endpoints News
An unpredictable year for healthcare
May 2025
citybiz
Venrock Healthcare Capital Partners Lead $155M Series B For AIRNA
Apr 2025
army.mil
Army SBIR|STTR and xTech Join Venrock and America’s Frontier Fund for first Demand Signal Forum at Stanford
Mar 2025
Endpoints News
Venrock adds $500M to healthcare investing strategy after outlining 10th fund in January
Nov 2024
PR Newswire
CASI Pharmaceuticals Announces $15 Million Private Placement Financing by Venrock Healthcare Capital Partners, Foresite Capital, Panacea Venture and Dr. Wei-Wu He
Jun 2024
STAT
Venture capitalist Bob Kocher on generative AI startups, Change Healthcare cyberattack
May 2024
Fierce Healthcare
Fierce Healthcare Fundraising Tracker—Ezra picks up $21M backed by Former One Medical CEO's VC
Feb 2024
fiercehealthcare.com
Integrated provider Accompany Health launches for low-income patients with $56M funding
Jan 2024
Fortune
Exclusive: Venrock ups its fund size for the first time in a decade, raising $650M for tenth fund
Jan 2024
InvestmentNews
Ex-Vanguard CEO joins venture capital firm to guide investments in advisor fintech
Aug 2023
Newcomer | Substack
Founder's Choice VC Rankings Revealed
Sep 2022
Business Insider
The healthtech industry is worried about startup investments cooling off in 2022 — here's why
Apr 2022
Fierce Biotech
Ocelot Bio gets a cool $36M series A and a new CEO to boot
Mar 2022
Axios
Scoop: Venrock leads $20 million Series B for SmithRx
Mar 2022
Axios
Venture capitalist David Pakman leaves Venrock for CoinFund
Sep 2021
WilmerHale
WilmerHale Advises Atom Computing in $15M Series A Funding
Aug 2021
TechCrunch
Venrock's Bryan Roberts on the firm's new $450 million fund, and where it's shopping in 2021
Jan 2021
The Nuclear Threat Initiative
Ray Rothrock
Jun 2020
venturecapitaljournal.com
Venrock raises nearly $450m for oversubscribed biotech fund
Apr 2020
Via Satellite
Microsatellite Startup Astranis Raises $90M, led by Venrock
Feb 2020
Los Angeles Business Journal
Fintech Startup Altruist Raises $8.5 Million
Nov 2019
STAT
Lessons Learned: This is how you become a venture capitalist in biotech
Jul 2018
The New York Times
Bryan Roberts of Venrock on Seeing Problems as Opportunities (Published 2017)
Oct 2017
MedCity News
Venrock raises a comfortable $450M for fund 8
Jan 2017
TechCrunch
Venrock Closes $450 Million Seventh Fund To Invest In Tech And Healthcare Startups
Jul 2014
Similar firms
Originating from a quantitative hedge fund, Two Sigma Ventures uses quant models and embeds data scientists, engineers, and researchers to tackle ML and data-pipeline challenges for AI, software infrastructure, and hardtech. The fund uses quantitative models and data science to support investment decisions and focuses specifically on companies that exploit the compounding of data and computing power, particularly in AI/ML, advanced software infrastructure, and hardtech at the intersection of climate, manufacturing, and life sciences.
Stealthy investor across frontier sectors (space, biotech, AI) making sub-$500K average checks into technically complex startups with exceptional defensibility and operational guidance from GP Rob Ness's 2% Rule.
8VC operates as both a venture capital fund and internal venture studio, dedicating 25-30% of their capital to co-founding startups through their Build program while assembling teams of top-1% specialists. The firm focuses on national capability companies in defense, industrials, and bio-infrastructure.
Digital health venture capital firm focused on companies enabling new care delivery models or more efficient therapeutic development.
Research briefRead more
Add Venrock to your investor list
Sign up free to save investors, see partner contacts, and track your raise.
Sign up